Terms Of Use | Privacy Policy




Gynecologic Cancers, Phase I Clinical Trials

Debra Richardson, MD, FACOG, FACS

Associate Professor, Section of Gynecologic Oncology, Oklahoma TSET Phase I Program

Debra Richardson, MD, FACOG, FACS, is an associate professor in the section of gynecologic oncology. She is also a part of the Oklahoma TSET Phase I Clinical Trials Program.

Dr. Richardson serves as a reviewer for various academic journals such as Obstetrics and Gynecology and Gynecologic Oncology.  She is an associate editor for the BioMed Central (BMC) Cancer publication.  She is a member of the Developmental Therapeutics and Ovarian Cancer committees for NRG Oncology.

In addition to her clinical work, Dr. Richardson focuses on prospective clinical studies and drug development.  Dr. Richardson served as the principal investigator for a randomized Phase II clinical trial in recurrent ovarian cancer patients.

Dr. Richardson attended medical school at New York Medical College.  She completed her Residency at University of Connecticut School of Medicine and her fellowship at The Ohio State University College of Medicine.  She is board certified in obstetrics and gynecology, and gynecologic oncology.


Fellowship: The Ohio State University College of Medicine, Columbus, OH
Residency: University of Connecticut School of Medicine, Farmington, CT
Medical School: New York Medical College, Valhalla, NY

Research Interests:

Gynecologic Cancers Phase I Clinical Trials

Honors and Awards:

Alpha Omega Alpha, 2001
Top 10% Reviewer, Obstetrics and Gynecology, 2014, 2015
Best Doctors in Dallas, D Magazine, 2014-2017
Castle Connoly Top Doctor of Dallas, 2017
Outstanding Reviewer, American Journal of Obstetrics and Gynecology, 2017

Professional Associations:

Alpha Omega Alpha Honor Society
American College of Obstetricians and Gynecologists, Fellow
Anerican College of Surgeons, Fellow
American Medical Association
American Society of Clinical Oncology
NRG Oncology
Society of Gynecologic Oncology
Western Association of Gynecologic Oncologists